ReP USP - Resultado da busca

Artigo de periodico
Coronary artery calcium to improve the efficiency of randomized controlled trials in primary cardiovascular prevention (2021)
Cainzos-Achirica, Miguel; Bittencourt, Márcio Sommer ; Osei, Albert D; Haque, Wagas; Bhatt, Deepak L; Blumenthal, Roger S; Blankstein, Ron; Ray, Kausik K; Blaha, Michael J; Nasir, Khurram
Source: JACC: Cardiovascular Imaging. Unidade: HU
Subjects: DOENÇAS CARDIOVASCULARES, VASOS CORONÁRIOS, CÁLCIO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAINZOS-ACHIRICA, Miguel et al. Coronary artery calcium to improve the efficiency of randomized controlled trials in primary cardiovascular prevention. JACC: Cardiovascular Imaging, v. 14, n. 5, p. 1005-1016, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jcmg.2020.10.016. Acesso em: 04 nov. 2024.
APA
Cainzos-Achirica, M., Bittencourt, M. S., Osei, A. D., Haque, W., Bhatt, D. L., Blumenthal, R. S., et al. (2021). Coronary artery calcium to improve the efficiency of randomized controlled trials in primary cardiovascular prevention. JACC: Cardiovascular Imaging, 14( 5), 1005-1016. doi:10.1016/j.jcmg.2020.10.016
NLM
Cainzos-Achirica M, Bittencourt MS, Osei AD, Haque W, Bhatt DL, Blumenthal RS, Blankstein R, Ray KK, Blaha MJ, Nasir K. Coronary artery calcium to improve the efficiency of randomized controlled trials in primary cardiovascular prevention [Internet]. JACC: Cardiovascular Imaging. 2021 ; 14( 5): 1005-1016.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.jcmg.2020.10.016
Vancouver
Cainzos-Achirica M, Bittencourt MS, Osei AD, Haque W, Bhatt DL, Blumenthal RS, Blankstein R, Ray KK, Blaha MJ, Nasir K. Coronary artery calcium to improve the efficiency of randomized controlled trials in primary cardiovascular prevention [Internet]. JACC: Cardiovascular Imaging. 2021 ; 14( 5): 1005-1016.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.jcmg.2020.10.016
Artigo de periodico
Usefulness of coronary artery calcium to identify adults of sufficiently high risk for atherothrombotic cardiovascular events to consider low-dose rivaroxaban thromboprophylaxis (from MESA) (2019)
Arps, Kelly; Al Rifai, Mahmoud; Blaha, Michael J; Michos, Erin D; Nasir, Khurram; Yeboah, Joseph; Budoff, Matthew J; Blumenthal, Roger S; Bittencourt, Márcio Sommer; McEvoy, John W
Source: American Journal of Cardiology. Unidade: HU
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, DOENÇAS CARDIOVASCULARES, TROMBOEMBOLISMO, FATORES DE RISCO, CÁLCIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARPS, Kelly et al. Usefulness of coronary artery calcium to identify adults of sufficiently high risk for atherothrombotic cardiovascular events to consider low-dose rivaroxaban thromboprophylaxis (from MESA). American Journal of Cardiology, v. 124, n. 8, p. 1198-1206, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.amjcard.2019.07.016. Acesso em: 04 nov. 2024.
APA
Arps, K., Al Rifai, M., Blaha, M. J., Michos, E. D., Nasir, K., Yeboah, J., et al. (2019). Usefulness of coronary artery calcium to identify adults of sufficiently high risk for atherothrombotic cardiovascular events to consider low-dose rivaroxaban thromboprophylaxis (from MESA). American Journal of Cardiology, 124( 8), 1198-1206. doi:10.1016/j.amjcard.2019.07.016
NLM
Arps K, Al Rifai M, Blaha MJ, Michos ED, Nasir K, Yeboah J, Budoff MJ, Blumenthal RS, Bittencourt MS, McEvoy JW. Usefulness of coronary artery calcium to identify adults of sufficiently high risk for atherothrombotic cardiovascular events to consider low-dose rivaroxaban thromboprophylaxis (from MESA) [Internet]. American Journal of Cardiology. 2019 ; 124( 8): 1198-1206.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.amjcard.2019.07.016
Vancouver
Arps K, Al Rifai M, Blaha MJ, Michos ED, Nasir K, Yeboah J, Budoff MJ, Blumenthal RS, Bittencourt MS, McEvoy JW. Usefulness of coronary artery calcium to identify adults of sufficiently high risk for atherothrombotic cardiovascular events to consider low-dose rivaroxaban thromboprophylaxis (from MESA) [Internet]. American Journal of Cardiology. 2019 ; 124( 8): 1198-1206.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.amjcard.2019.07.016
Artigo de periodico
The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis (2017)
Gupta, Ankur; Lau, Emily; Varshney, Ravi; Hulten, Edward; Cheezum, Michael; Bittencourt, Márcio Sommer; Blaha, Michael J; Wong, Nathan D; Blumenthal, Roger S; Budoff, Matthew J; Umscheid, Craig A; Nasir, Khurram; Blankstein, Ron
Source: JACC: Cardiovascular Imaging. Unidade: HU
Subjects: DOENÇAS CARDIOVASCULARES, CÁLCIO, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUPTA, Ankur et al. The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis. JACC: Cardiovascular Imaging, v. 10, n. 8, p. 833-842, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jcmg.2017.01.030. Acesso em: 04 nov. 2024.
APA
Gupta, A., Lau, E., Varshney, R., Hulten, E., Cheezum, M., Bittencourt, M. S., et al. (2017). The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis. JACC: Cardiovascular Imaging, 10( 8), 833-842. doi:10.1016/j.jcmg.2017.01.030
NLM
Gupta A, Lau E, Varshney R, Hulten E, Cheezum M, Bittencourt MS, Blaha MJ, Wong ND, Blumenthal RS, Budoff MJ, Umscheid CA, Nasir K, Blankstein R. The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis [Internet]. JACC: Cardiovascular Imaging. 2017 ; 10( 8): 833-842.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.jcmg.2017.01.030
Vancouver
Gupta A, Lau E, Varshney R, Hulten E, Cheezum M, Bittencourt MS, Blaha MJ, Wong ND, Blumenthal RS, Budoff MJ, Umscheid CA, Nasir K, Blankstein R. The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis [Internet]. JACC: Cardiovascular Imaging. 2017 ; 10( 8): 833-842.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.jcmg.2017.01.030
Artigo de periodico
Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis) (2015)
Nasir, Khurram; Bittencourt, Márcio Sommer; Blaha, Michael J; Blankstein, Ron; Agatson, Arthur S; Rivera, Juan J; Miedema, Michael D; Sibley, Christopher T; Shaw, Leslee J; Blumenthal, Roger S; Budoff, Matthew J; Krumholz, Harlan M
Source: Journal of the American College of Cardiology. Unidade: HU
Subjects: ARTERIOSCLEROSE, COLESTEROL, AVALIAÇÃO DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASIR, Khurram et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology, v. 66, n. 15, p. 1657-1668, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2015.07.066. Acesso em: 04 nov. 2024.
APA
Nasir, K., Bittencourt, M. S., Blaha, M. J., Blankstein, R., Agatson, A. S., Rivera, J. J., et al. (2015). Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology, 66( 15), 1657-1668. doi:10.1016/j.jacc.2015.07.066
NLM
Nasir K, Bittencourt MS, Blaha MJ, Blankstein R, Agatson AS, Rivera JJ, Miedema MD, Sibley CT, Shaw LJ, Blumenthal RS, Budoff MJ, Krumholz HM. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis) [Internet]. Journal of the American College of Cardiology. 2015 ; 66( 15): 1657-1668.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.jacc.2015.07.066
Vancouver
Nasir K, Bittencourt MS, Blaha MJ, Blankstein R, Agatson AS, Rivera JJ, Miedema MD, Sibley CT, Shaw LJ, Blumenthal RS, Budoff MJ, Krumholz HM. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis) [Internet]. Journal of the American College of Cardiology. 2015 ; 66( 15): 1657-1668.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.jacc.2015.07.066
Artigo de periodico
Polypill therapy, subclinical atherosclerosis, and cardiovascular events: implications for the use of preventive pharmacotherapy MESA (Multi-Ethnic Study of Atherosclerosis) (2014)
Bittencourt, Márcio Sommer; Blaha, Michael J; Blankstein, Ron; Budoff, Matthew; Vargas, Jose D; Blumenthal, Roger S; Agatston, Arthur S; Nasir, Khurram
Source: Journal of the American College of Cardiology. Unidade: HU
Subjects: ARTERIOSCLEROSE (PREVENÇÃO E CONTROLE), DOENÇAS METABÓLICAS, CÁLCIO, VASOS CORONÁRIOS (METABOLISMO), GRUPOS ÉTNICOS, ANGIOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer et al. Polypill therapy, subclinical atherosclerosis, and cardiovascular events: implications for the use of preventive pharmacotherapy MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology, v. 63, n. 5, p. 434-443, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2013.08.1640. Acesso em: 04 nov. 2024.
APA
Bittencourt, M. S., Blaha, M. J., Blankstein, R., Budoff, M., Vargas, J. D., Blumenthal, R. S., et al. (2014). Polypill therapy, subclinical atherosclerosis, and cardiovascular events: implications for the use of preventive pharmacotherapy MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology, 63( 5), 434-443. doi:10.1016/j.jacc.2013.08.1640
NLM
Bittencourt MS, Blaha MJ, Blankstein R, Budoff M, Vargas JD, Blumenthal RS, Agatston AS, Nasir K. Polypill therapy, subclinical atherosclerosis, and cardiovascular events: implications for the use of preventive pharmacotherapy MESA (Multi-Ethnic Study of Atherosclerosis) [Internet]. Journal of the American College of Cardiology. 2014 ; 63( 5): 434-443.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.jacc.2013.08.1640
Vancouver
Bittencourt MS, Blaha MJ, Blankstein R, Budoff M, Vargas JD, Blumenthal RS, Agatston AS, Nasir K. Polypill therapy, subclinical atherosclerosis, and cardiovascular events: implications for the use of preventive pharmacotherapy MESA (Multi-Ethnic Study of Atherosclerosis) [Internet]. Journal of the American College of Cardiology. 2014 ; 63( 5): 434-443.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.jacc.2013.08.1640

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation